MHLW Warns of Hyperbilirubinemia in Patients on Sovriad

November 27, 2014
The Ministry of Health, Labor and Welfare (MHLW) once again warned of the hepatitis C drug Sovriad Capsules 100 mg (simeprevir sodium) in a pharmaceutical safety information bulletin on November 25, a month after the ministry requested the maker Janssen...read more